|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Depreciation and amortization | |||||
| Net (Loss) / Income | |||||
| Adjustments to reconcile net (Loss) / Income to net cash used in operating activities: | |||||
| Impairment of intangible asset | |||||
| Impairment of goodwill | |||||
| Change in fair value of compensation | |||||
| Depreciation and amortization expenses | |||||
| Gain / (loss) on fair value remeasurement | |||||
| Stock-based expenses | |||||
| Gain on extinguishments of debt | |||||
| Unrealized gain, net of income tax | |||||
| Warrant modification expense | |||||
| Change in fair value of stock-based compensation | |||||
| Amortization of debt discount | |||||
| Unrealized gain / (loss), net of income tax | |||||
| Loss on extinguishment of debt | |||||
| Impairment of assets | |||||
| Foreign exchange translation adjustment | |||||
| Loss on disposal of assets | |||||
| Bad debt expense | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Operating right to use assets and lease liabilities, net | |||||
| Other current assets | |||||
| Other non-current assets | |||||
| Accounts payable and accrued expenses | |||||
| Other current liabilities | |||||
| Contract liability, non-current | |||||
| Deferred rent | |||||
| Other non-current liabilities | |||||
| Deferred revenue | |||||
| Total adjustments | |||||
| Net cash used in operating activities | |||||
| Net cash used in operating activities - discontinued operations | |||||
| Cash Flows from Investing Activities | |||||
| Deposit on farmland | |||||
| Investment from non-controlling interest | |||||
| Purchases of property and equipment | |||||
| Disposal of property and equipment | |||||
| Collections from notes receivable | |||||
| Net cash used in investing activities | |||||
| Net cash provided by (used in) investing activities | |||||
| Net cash provided by investing activities - discontinued operations | |||||
| Proceeds from notes payable | |||||
| Repayments of notes payables | |||||
| Proceeds from exercise of warrants | |||||
| Net cash provided by / (used in) financing activities | |||||
| Debt Discount | |||||
| Proceeds from issuance of common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Net cash used in financing activities - discontinued operations | |||||
| Net Change in Cash | |||||
| Cash – beginning of period (includes $0.27 million of restricted cash as of December 31, 2025 and 2024) | |||||
| Cash – end of period (includes $0.27 million of restricted cash as of December 31, 2025 and 2024) | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Cash paid for interest and taxes | |||||
| Supplemental Disclosures of Non-Cash Investing and Financing Activities | |||||
| Conversion of notes payable into common stock | |||||
| Conversion of stock | |||||
| Exchange of accounts receivable for equity securities | |||||
| Issuance of equity securities to settle accounts payable | |||||
| Issuance of common stock as equity issuance costs | |||||
Loading...